Streamlining Impurity Analysis in Atorvastatin with the ACQUITY™ QDa™ II Mass Detector for Enhanced Detection and Quantification

Applications | 2024 | WatersInstrumentation
LC/MS, LC/SQ
Industries
Pharma & Biopharma
Manufacturer
Waters
Downloadable PDF for viewing
 

Similar PDF

Expediting Method Development for Oligonucleotide Impurity Analysis Using the ACQUITY™ QDa™ II Mass Detector
Waters ACQUITY QDa Detector - QC APPLICATIONS COMPENDIUM - EDITION 2
Analytical Scale Isolation and Purification of Propranolol Impurities Including Nitrosamine Drug Substance Related Impurity (NDSRI)
Accelerating Method Development and Manufacturing of GLP-1 Analogs with LCUV/ MS